These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 16808622)
21. The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models. Evans S; Dizeyi N; Abrahamsson PA; Persson J Anticancer Res; 2009 Oct; 29(10):3917-24. PubMed ID: 19846929 [TBL] [Abstract][Full Text] [Related]
22. Dietary genistein inhibits metastasis of human prostate cancer in mice. Lakshman M; Xu L; Ananthanarayanan V; Cooper J; Takimoto CH; Helenowski I; Pelling JC; Bergan RC Cancer Res; 2008 Mar; 68(6):2024-32. PubMed ID: 18339885 [TBL] [Abstract][Full Text] [Related]
23. Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model. Hillman GG; Wang Y; Che M; Raffoul JJ; Yudelev M; Kucuk O; Sarkar FH BMC Cancer; 2007 Jan; 7():4. PubMed ID: 17212824 [TBL] [Abstract][Full Text] [Related]
25. Novel syngeneic pseudo-orthotopic prostate cancer model: vascular, mitotic and apoptotic responses to castration. Frost GI; Lustgarten J; Dudouet B; Nyberg L; Hartley-Asp B; Borgström P Microvasc Res; 2005 Jan; 69(1-2):1-9. PubMed ID: 15797254 [TBL] [Abstract][Full Text] [Related]
26. Patupilone (epothilone B, EPO906) inhibits growth and metastasis of experimental prostate tumors in vivo. O'Reilly T; McSheehy PM; Wenger F; Hattenberger M; Muller M; Vaxelaire J; Altmann KH; Wartmann M Prostate; 2005 Nov; 65(3):231-40. PubMed ID: 15948135 [TBL] [Abstract][Full Text] [Related]
27. Comparison of two in vivo models for prostate cancer: orthotopic and intratesticular inoculation of LNCaP or PC-3 cells. Koshida K; Konaka H; Imao T; Egawa M; Mizokami A; Namiki M Int J Urol; 2004 Dec; 11(12):1114-21. PubMed ID: 15663685 [TBL] [Abstract][Full Text] [Related]
28. Human glioblastoma and carcinoma xenograft tumors treated by combined radiation and imatinib (Gleevec). Oertel S; Krempien R; Lindel K; Zabel A; Milker-Zabel S; Bischof M; Lipson KE; Peschke P; Debus J; Abdollahi A; Huber PE Strahlenther Onkol; 2006 Jul; 182(7):400-7. PubMed ID: 16826359 [TBL] [Abstract][Full Text] [Related]
29. Real-time whole-body imaging of an orthotopic metastatic prostate cancer model expressing red fluorescent protein. Yang M; Jiang P; Yamamoto N; Li L; Geller J; Moossa AR; Hoffman RM Prostate; 2005 Mar; 62(4):374-9. PubMed ID: 15389802 [TBL] [Abstract][Full Text] [Related]
30. Prophylactic noscapine therapy inhibits human prostate cancer progression and metastasis in a mouse model. Barken I; Geller J; Rogosnitzky M Anticancer Res; 2010 Feb; 30(2):399-401. PubMed ID: 20332445 [TBL] [Abstract][Full Text] [Related]
31. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. Guo Y; Wang S; Hoot DR; Clinton SK J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033 [TBL] [Abstract][Full Text] [Related]
34. Pegylated kunitz domain inhibitor suppresses hepsin-mediated invasive tumor growth and metastasis. Li W; Wang BE; Moran P; Lipari T; Ganesan R; Corpuz R; Ludlam MJ; Gogineni A; Koeppen H; Bunting S; Gao WQ; Kirchhofer D Cancer Res; 2009 Nov; 69(21):8395-402. PubMed ID: 19843851 [TBL] [Abstract][Full Text] [Related]
35. Enhancement of radiation response of prostatic carcinoma by lonidamine. Dudak SD; Lopez A; Block NL; Lokeshwar BL Anticancer Res; 1996; 16(6B):3665-71. PubMed ID: 9042239 [TBL] [Abstract][Full Text] [Related]
36. Radiosensitization and modulation of p44/42 mitogen-activated protein kinase by 2-Methoxyestradiol in prostate cancer models. Casarez EV; Dunlap-Brown ME; Conaway MR; Amorino GP Cancer Res; 2007 Sep; 67(17):8316-24. PubMed ID: 17804747 [TBL] [Abstract][Full Text] [Related]
37. Akt GSK-3 pathway as a target in genistein-induced inhibition of TRAMP prostate cancer progression toward a poorly differentiated phenotype. El Touny LH; Banerjee PP Carcinogenesis; 2007 Aug; 28(8):1710-7. PubMed ID: 17468512 [TBL] [Abstract][Full Text] [Related]
38. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models. Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998 [TBL] [Abstract][Full Text] [Related]
39. Effect of a metalloporphyrin antioxidant (MnTE-2-PyP) on the response of a mouse prostate cancer model to radiation. Makinde AY; Luo-Owen X; Rizvi A; Crapo JD; Pearlstein RD; Slater JM; Gridley DS Anticancer Res; 2009 Jan; 29(1):107-18. PubMed ID: 19331139 [TBL] [Abstract][Full Text] [Related]
40. Does local hyperthermia affect metastasis of a human prostate carcinoma grown in athymic nude mice? Greenstein A; Koontz WW Int J Hyperthermia; 2002; 18(4):285-91. PubMed ID: 12079584 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]